Re-gen Active Lab stands as a premier FDA-registered tissue establishment dedicated to advancing the field of regenerative science. Since its inception in 2018, the clinic has specialized in developing biomolecules derived from human umbilical cord and amniotic membrane tissues. By partnering exclusively with AABB-accredited cord banks, the clinic ensures that all sourced tissue originates from healthy, full-term, scheduled C-section births in U.S. hospitals. This commitment to ethical and regulated sourcing is complemented by rigorous donor screening and testing protocols, which guarantee that only the highest quality tissue is utilized in their product offerings.
The clinic's state-of-the-art manufacturing processes take place within an ISO Class 3 certified cleanroom, supported by ISO Class 7 areas, ensuring strict environmental and process controls. Each batch of products, which includes a diverse array of naturally occurring biomolecules such as exosomes, proteins, peptides, and growth factors, undergoes extensive independent testing for sterility and endotoxin levels prior to release. Re-gen Active Lab is dedicated to maintaining batch consistency and quality, providing clinics and research organizations nationwide with confidence in their offerings. By emphasizing safety, transparency, and regulatory compliance, the clinic positions itself as a trusted leader in regenerative tissue science, making it an invaluable resource for professionals seeking high-quality biomolecule-rich products.